Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer

This study has been terminated.
(Study was terminated due to lack of accrual)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
OHSU Knight Cancer Institute Identifier:
First received: August 14, 2007
Last updated: July 23, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)